February 2004
Digestive Diagnostics
The latest biotech "-omics," metabolomics, could lead to earlier detection of a wide array of diseases.
By Corie Lok
Meet another installment in biotech's "-omics" series: metabolomics. While doctors have been charting levels of individual metabolites like cholesterol for years, a growing number of researchers are measuring hundreds of metabolites-fatty acids, amino acids, and sugars produced by cells' everyday activities-more systematically. They say this will enable earlier diagnoses of a wide array of diseases and provide a set of new tools for developing safer drugs.
![]() | Select from the choices above to read the entire article. |
Customer Service
|
Magazine Services
|
Subscribe
|
Other
|
Advertise
|


